French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's consumer health business Opella, the Le Monde newspaper said on Thursday, as PAI seeks to outbid U.S. rival ...

France’s Economy Minister has warned that the government could block the sale of a subsidiary of the French pharmaceutical ...

Clayton Dubilier & Rice is working on a package of commitments amid political concerns that its purchase of a controlling ...

The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after ...

The French government is looking at options including taking a public stake in the consumer health business that Sanofi is in ...

Denali Therapeutics and Sanofi have decided to discontinue a drug trial aimed at treating multiple sclerosis. The experimental drug failed to achieve the necessary study goals, marking a setback in ...

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a deal is indeed brewing. Sanofi has entered negotiations with private ...

Sanofi has stopped a phase 2 trial of Denali Therapeutics-partnered oditrasertib in multiple sclerosis. The French drugmaker tore the RIPK1 inhibitor trial from its list of active studies after it ...

PARIS - Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, the French pharmaceutical group said ...

For the past year, French pharmaceutical giant Sanofi has been searching for a buyer to take control of its consumer health business. That search may now be over. On Friday, Sanofi said it’s in ...

The Pakistan Development Update (PDU) is the World Bank Pakistan flagship report that discusses the latest macroeconomic developments and policy issues that are critical to the country’s long-term ...